Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT

Affiliations

• ¹ Department of Hematology, Hôpital Saint-Antoine, Paris, France.
• ² Department of Medicine, Hematology and Bone Marrow Transplant Unit, Verona University, Verona, Italy.
• ³ Acute Leukemia Working Party of EBMT, Paris, France.
• ⁴ Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
• ⁵ Department of Hematology - BMT, Hôpital Saint-Louis, Paris, France.
• ⁶ Department of Hematology II, Ospedale San Martino, Genova, Italy.
• ⁷ Department of Hematology, Hospital U. Marqués de Valdecilla, Santander, Spain.
• ⁸ Centre Hospitalier Universitaire de Lille, Université de Lille, INSERM U1286, Lille, France.
• ⁹ Oncology (Section of Adult Hematolgy/BMT), King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
• ¹⁰ Department of Hematology, Addenbrooke's Hospital, Cambridge, UK.
• ¹¹ Department of Clinical Hematology of the Adult, Centre Hospitalier Universitaire de Rennes, Rennes, France.
• ¹² Department of Oncology, Oncohematology and Bone Marrow Transplant Unit, Ospedale La Maddalena, Palermo, Italy.
• ¹³ Division of Hematology, Azienda Ospedaliero Universitaria di Udine, Udine, Italy.
• ¹⁴ Department of Hematological Medicine, King's College Hospital, King's Denmark Hill Campus, London, UK.
• ¹⁵ Department of Clinical Hematology, CHU Limoges, Limoges, France.
• ¹⁶ Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
• ¹⁷ Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milano, Italy.
• ¹⁸ Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.